HOME >> MEDICINE >> NEWS
Robotic surgery-stenting combo opens coronary arteries, speeds recovery

Combining robotically assisted coronary artery bypass surgery (CABG) with stented angioplasty shows promise for treating extensive coronary artery disease, researchers reported at the American Heart Association Scientific Sessions 2005.

"The minimally invasive procedure effectively bypassed or opened blocked arteries in all 27 patients, an outcome as good or better than you would expect with open chest surgery," said Marc R. Katz, M.D., lead author of the study and chief of cardiac surgery and director of the Virginia Transplant Center at Henrico Doctors' Hospital in Richmond.

"The patients stayed in the hospital an average of only two and a half days, compared with five or six days for conventional CABG surgery," Katz said. "And they were back to work in a week or so, compared with the usual six to 12 weeks."

The study involved patients with multi-vessel coronary disease, including obstruction of the left anterior descending coronary artery (LAD), the main artery in the front of the heart.

During the closed-chest bypass procedure, the left internal mammary artery (in the chest) was harvested. Doctors then sutured the mammary artery to the obstructed LAD, bypassing the obstruction, all done endoscopically.

During the angioplasty procedure, doctors used stents (mesh tubes) to unblock other arteries and then prop them open.

"Using the left internal mammary artery to bypass the LAD is the one thing we can do for patients with coronary artery disease that has a proven survival advantage," Katz said. "Here is a way to accomplish that and also open other vessels in a very minimally invasive way."

Robotic surgery involves making three small incisions, each about 1 cm ( inch) long, in the left side of the patient's chest. A 3-D scope with 10x magnification is inserted in the middle port, with the robotic right and left arms in the other ports. The daVinci robotic system is a powerful computer interface that al
'"/>

Contact: Carole Bullock or Karen Astle
carole.bullock@heart.org
214-706-1396
American Heart Association
16-Nov-2005


Page: 1 2

Related medicine news :

1. Springer debuts Journal of Robotic Surgery
2. Robotic treadmill training helps retrain brain, improves walking
3. Robotic technique shows promise in weight-loss surgery, Stanford study finds
4. Radiation therapy combo cures prostate cancer long-term
5. Making headway against hepatitis C: SLU study shows new drug combo effective in nonresponders
6. Drug combo improves survival in patients with COPD
7. Gold nanoparticles, radiation combo may slow Alzheimers
8. New study: Drug combo against AIDS-related infections also prevents malaria
9. PRESERVE- 2-year study of initial combo therapy with nateglinide or glyburide + metformin
10. Hepatitis C responds best to combo of ribavirin and interferon, study concludes
11. Nanomedicine opens the way for nerve cell regeneration

Post Your Comments:
(Date:7/30/2015)... Marathon, FL (PRWEB) , ... July 30, 2015 ... ... streaming software, TikiLIVE, has worked to protect victims in San Diego, California’s Gaslamp ... cameras used by Gaslamp Quarter Plaza actively monitor the area for any ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... growing into one of the largest, family-owned low cost service and repair companies. ... commercial applications, as well as growing their company to meet the demands of ...
(Date:7/30/2015)... CA (PRWEB) , ... July ... ... recently released a video, “Beachside Nursing Center,” to announce its position as ... five-star ratings. Beachside's administrator and staff members support the CMS rating system, ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Ross A. ... College of Medicine as Assistant Professor of Plastic Surgery. This is Dr. Clevens’ ... has worked closely with the university, developing a strong presence and a valuable mentoring ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Using the latest ... and teach people more effective ways to prevent and manage major depression. , “Suicide ... fast enough, so people fall through the cracks and die needlessly everyday,” says Walker. ...
Breaking Medicine News(10 mins):Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 2Health News:Eyepartner Software Helps Victims in Gaslamp Quarter Plaza 3Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 2Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 3Health News:Beachside Nursing Center Releases New Video 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3
(Date:7/30/2015)... , July 30, 2015 Tianyin Pharmaceutical ... pharmaceutical company that specializes in the patented biopharmaceutical, modernized ... ingredients (API), provided updates regarding the notice it received ... (the "Exchange") indicating that the Company was below certain ... in Sections 134 and 1101 of the NYSE MKT ...
(Date:7/30/2015)... , July 30, 2015  Growth of the ... as they bring former prescription users to the OTC ... Kline forecasts robust Rx-to-OTC switch activity over the ... emerging along with many new brands entering the market ... over the next five years (even those with low ...
(Date:7/30/2015)... FAIRFIELD, N.J. , July 30, 2015 /PRNewswire/ ... Ferrer, completed the second Phase III clinical study ... development for impetigo.  Medimetriks owns the exclusive U.S. ... The global trial, conducted at 44 centers with ... and pediatric patients aged 2 months and older ...
Breaking Medicine Technology:TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3
Cached News: